FOXD2 and breast cancer: These findings suggest that lncRNA FOXD2-AS1 can promote the proliferation and migration of breast cancer cells, inhibit apoptosis, affect the drug resistance of breast cancer cells, and promote the malignant biological behavior of breast cancer.